Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Jonathan Anker; Sumanta K Pal; Seunghee Kim-Schulze; Huan Wang; Rebecca Halperin; Andrew Uzilov; Naoko Imai; Shingo Eikawa; Takuro Saito; Robert Sebra; Noah M Hahn; Manishkumar Patel; Jingjing Qi; Hui Xie; Nina Bhardwaj; Sacha Gnjatic; Matthew D Galsky

doi:10.1136/jitc-2023-007613

Article info

Clinical/translational cancer immunotherapy

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Authors

Jonathan Anker Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Sumanta K Pal Department of Hematology and Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California, USA PubMed articles Google scholar articles
Seunghee Kim-Schulze Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USAHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Huan Wang Sema4, Branford, Connecticut, USA PubMed articles Google scholar articles
Rebecca Halperin Sema4, Branford, Connecticut, USA PubMed articles Google scholar articles
Andrew Uzilov Sema4, Branford, Connecticut, USA PubMed articles Google scholar articles
Naoko Imai Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Shingo Eikawa Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Takuro Saito Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USAOsaka University School of Medicine Graduate School of Medicine, Suita, Osaka, Japan PubMed articles Google scholar articles
Robert Sebra Sema4, Branford, Connecticut, USADepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Noah M Hahn Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articles Google scholar articles
Manishkumar Patel Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Jingjing Qi Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Hui Xie Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Nina Bhardwaj Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Sacha Gnjatic Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USAHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles
Matthew D Galsky Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articles Google scholar articles

Citation

Anker J, Pal SK, Kim-Schulze S, et al

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer

Journal for ImmunoTherapy of Cancer 2023;11:e007613. doi: 10.1136/jitc-2023-007613

Online issue publication

August 22, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password